John Hopper, who has successfully led FCF for the past eight years, has informed us that he would like to step back and focus his efforts on special initiatives, including fund advancement. John’s new focus as President Emeritus will be critically important to accelerating FCF’s research efforts by providing additional funding for research. We are very appreciative of all John has done and are pleased that he will remain a key member of FCF’s management team and board of directors.
We are extremely pleased to report that Kurt Losert will become the CEO of FCF going forward. Kurt has been very actively involved with the Foundation for the past two years in efforts including redesigning our website and running our first Patient & Research Summit. His expertise and commitment to this cause is inspiring. In addition to facing the loss of his wife due to fibrolamellar carcinoma, Kurt brings to FCF experience as a management consultant and technology executive, having worked for McKinsey & Company, Compaq and several small software and services companies. We are grateful that Kurt has stepped up to lead the organization.
FCF is in its 14th year. Much has been accomplished. Much, much more is left to be done. We are exceedingly grateful to John, Kurt, Anne, Lynn, Megen, Mark, Patty, The Board, Stone Point and all who have been helpful in this effort, and we move ahead with optimism and enthusiasm.
Keep on Tuckin’!
Marna Davis & Chuck Davis, Co-Chairmen